235 related articles for article (PubMed ID: 14673140)
1. Upregulation of the Catalytic Telomerase Subunit by the Transcription Factor ER81 and Oncogenic HER2/Neu, Ras, or Raf.
Goueli BS; Janknecht R
Mol Cell Biol; 2004 Jan; 24(1):25-35. PubMed ID: 14673140
[TBL] [Abstract][Full Text] [Related]
2. Acetylation-mediated transcriptional activation of the ETS protein ER81 by p300, P/CAF, and HER2/Neu.
Goel A; Janknecht R
Mol Cell Biol; 2003 Sep; 23(17):6243-54. PubMed ID: 12917345
[TBL] [Abstract][Full Text] [Related]
3. Regulation of Her2/neu promoter activity by the ETS transcription factor, ER81.
Bosc DG; Janknecht R
J Cell Biochem; 2002; 86(1):174-83. PubMed ID: 12112028
[TBL] [Abstract][Full Text] [Related]
4. HER2/Neu- and TAK1-mediated up-regulation of the transforming growth factor beta inhibitor Smad7 via the ETS protein ER81.
Dowdy SC; Mariani A; Janknecht R
J Biol Chem; 2003 Nov; 278(45):44377-84. PubMed ID: 12947087
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of telomerase activity: roles of the the Ets transcription factor family.
Dwyer J; Li H; Xu D; Liu JP
Ann N Y Acad Sci; 2007 Oct; 1114():36-47. PubMed ID: 17986575
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional activation of hTERT in breast carcinomas by the Her2-ER81-related pathway.
Vageli D; Ioannou MG; Koukoulis GK
Oncol Res; 2009; 17(9):413-23. PubMed ID: 19718948
[TBL] [Abstract][Full Text] [Related]
7. The PEA3 Ets transcription factor is a downstream target of the HER2/Neu receptor tyrosine kinase.
O'Hagan RC; Hassell JA
Oncogene; 1998 Jan; 16(3):301-10. PubMed ID: 9467955
[TBL] [Abstract][Full Text] [Related]
8. HER2/Neu-mediated activation of the ETS transcription factor ER81 and its target gene MMP-1.
Bosc DG; Goueli BS; Janknecht R
Oncogene; 2001 Sep; 20(43):6215-24. PubMed ID: 11593430
[TBL] [Abstract][Full Text] [Related]
9. Regulation of telomerase reverse transcriptase gene activity by upstream stimulatory factor.
Goueli BS; Janknecht R
Oncogene; 2003 Sep; 22(39):8042-7. PubMed ID: 12970752
[TBL] [Abstract][Full Text] [Related]
10. Rcl is a novel ETV1/ER81 target gene upregulated in breast tumors.
Shin S; Bosc DG; Ingle JN; Spelsberg TC; Janknecht R
J Cell Biochem; 2008 Oct; 105(3):866-74. PubMed ID: 18726892
[TBL] [Abstract][Full Text] [Related]
11. The epithelial-specific ETS transcription factor ESX/ESE-1/Elf-3 modulates breast cancer-associated gene expression.
Eckel KL; Tentler JJ; Cappetta GJ; Diamond SE; Gutierrez-Hartmann A
DNA Cell Biol; 2003 Feb; 22(2):79-94. PubMed ID: 12713734
[TBL] [Abstract][Full Text] [Related]
12. Direct activation of telomerase by EGF through Ets-mediated transactivation of TERT via MAP kinase signaling pathway.
Maida Y; Kyo S; Kanaya T; Wang Z; Yatabe N; Tanaka M; Nakamura M; Ohmichi M; Gotoh N; Murakami S; Inoue M
Oncogene; 2002 Jun; 21(26):4071-9. PubMed ID: 12037663
[TBL] [Abstract][Full Text] [Related]
13. Concerted activation of ETS protein ER81 by p160 coactivators, the acetyltransferase p300 and the receptor tyrosine kinase HER2/Neu.
Goel A; Janknecht R
J Biol Chem; 2004 Apr; 279(15):14909-16. PubMed ID: 14747462
[TBL] [Abstract][Full Text] [Related]
14. ETS variant transcription factor 5 and c-Myc cooperate in derepressing the human telomerase gene promoter via composite ETS/E-box motifs.
Zhang F; Wang S; Zhu J
J Biol Chem; 2020 Jul; 295(29):10062-10075. PubMed ID: 32518154
[TBL] [Abstract][Full Text] [Related]
15. Antitumoral actions of the anti-obesity drug orlistat (XenicalTM) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene.
Menendez JA; Vellon L; Lupu R
Ann Oncol; 2005 Aug; 16(8):1253-67. PubMed ID: 15870086
[TBL] [Abstract][Full Text] [Related]
16. The involvement of HER2 and p53 status in the regulation of telomerase in irradiated breast cancer cells.
Papanikolaou V; Iliopoulos D; Dimou I; Dubos S; Tsougos I; Theodorou K; Kitsiou-Tzeli S; Tsezou A
Int J Oncol; 2009 Nov; 35(5):1141-9. PubMed ID: 19787269
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic Neu/ErbB-2 increases ets, AP-1, and NF-kappaB-dependent gene expression, and inhibiting ets activation blocks Neu-mediated cellular transformation.
Galang CK; García-Ramírez J; Solski PA; Westwick JK; Der CJ; Neznanov NN; Oshima RG; Hauser CA
J Biol Chem; 1996 Apr; 271(14):7992-8. PubMed ID: 8626480
[TBL] [Abstract][Full Text] [Related]
18. Induction of hTERT expression and phosphorylation by estrogen via Akt cascade in human ovarian cancer cell lines.
Kimura A; Ohmichi M; Kawagoe J; Kyo S; Mabuchi S; Takahashi T; Ohshima C; Arimoto-Ishida E; Nishio Y; Inoue M; Kurachi H; Tasaka K; Murata Y
Oncogene; 2004 Jun; 23(26):4505-15. PubMed ID: 15048073
[TBL] [Abstract][Full Text] [Related]
19. Functional components of fibroblast growth factor (FGF) signal transduction in pituitary cells. Identification of FGF response elements in the prolactin gene.
Schweppe RE; Frazer-Abel AA; Gutierrez-Hartmann A; Bradford AP
J Biol Chem; 1997 Dec; 272(49):30852-9. PubMed ID: 9388230
[TBL] [Abstract][Full Text] [Related]
20. Induction of endogenous telomerase (hTERT) by c-Myc in WI-38 fibroblasts transformed with specific genetic elements.
Casillas MA; Brotherton SL; Andrews LG; Ruppert JM; Tollefsbol TO
Gene; 2003 Oct; 316():57-65. PubMed ID: 14563552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
